Since 1986 California Clinical Trials (CCT) has been at the forefront of drug development. Our best-in-class clinical experts, research staff, and trained physicians all work together seamlessly to bring hope to patients around the world. Our executive team comprises outstanding leaders in medical science. Whether you need careful patient selection for your Phase 1 studies, or experience in drug development and research for Phase II-IV operations, CCT quality and performance allow you to make “go/no-go” decisions about your products. With our help, you get your products to market, fast.

In 2003 CCT moved its Early Drug Development unit into a wing at Glendale Adventist Medical Center in Glendale, California. This makes us the only hospital-based Phase I Unit in Southern California. And CCT guarantees consistency of procedures and superior performance across all of our locations. Our clinical investigative sites in Glendale, Los Angeles, Culver City, and San Diego, as well as our two sleep centers make a powerhouse single-source solution for your clinical trial needs. Additionally, with the purchase of CCT by Parexel, there will be an expansion of sleep beds to further demonstrate our dominance.